Furthermore, there was a significant correlation between COL3A1 and EMP1 in osteoblasts (Figure 7F), suggesting the enrichment of COL3A1+/EMP1+ cells during the BoM process in prostate cancer. The gene discussed is GRHL2; the disease is prostate carcinoma.